Prescribing a Balance: Sustaining Environmental Health with Pharmaceutical Interest in Puerto Rico

Puerto Rico, often referred to as the “Medical Cabinet of the U.S.A.,” is a hub for pharmaceutical manufacturing, contributing significantly to the American medical supply chain and Puerto Rico’s economy. However, decades of industrial activity, compounded by climate events like Hurricane Maria, have led to severe environmental damage, particularly through groundwater contamination and damaged Superfund sites. This Note examines the historical intersection of economic incentives and environmental neglect in Puerto Rico, focusing on the pharmaceutical industry’s impact. By critically analyzing the Superfund program and proposing reforms, this Note advocates for a balanced approach: introducing proactive environmental protections and financial incentives for compliant pharmaceutical manufacturers. Such measures aim to sustain pharmaceutical investments while safeguarding Puerto Rico’s fragile environment, public health, and long-term economic resilience.